#pancreatic_cancer
LightNews LightNews
newsen.bsky.social
Significant Disparities in Pancreatic Cancer Treatment Identified in Latest Research#USA#pancreatic_cancer#Plymouth_Meeting#Health_Disparities#JNCCN
Significant Disparities in Pancreatic Cancer Treatment Identified in Latest Research
A recent study has revealed critical disparities in treatment and survival rates among pancreatic cancer patients, affecting marginalized groups disproportionately in the U.S.
third-news.com
April 10, 2025 at 3:32 PM
newsen.bsky.social
Diakonos Oncology to Showcase Pancreatic Cancer Trial Data at SITC Annual Meeting#USA#pancreatic_cancer#Diakonos_Oncology#DOC1021#National_Harbor,_MD
Diakonos Oncology to Showcase Pancreatic Cancer Trial Data at SITC Annual Meeting
Diakonos Oncology is set to present promising data from clinical trials on their innovative DOC1021 immunotherapy targeting pancreatic cancer at SITC 40th Annual Meeting.
third-news.com
October 27, 2025 at 12:25 PM
newsen.bsky.social
Novita Pharmaceuticals Secures FDA Orphan Drug Designation for Pancreatic Cancer Treatment#USA#New_York#pancreatic_cancer#Novita_Pharmaceuticals#NP-G2-044
Novita Pharmaceuticals Secures FDA Orphan Drug Designation for Pancreatic Cancer Treatment
Novita Pharmaceuticals has received FDA Orphan Drug Designation for NP-G2-044, a promising treatment for pancreatic cancer, enhancing hope for patients.
third-news.com
January 12, 2026 at 1:23 PM
newsen.bsky.social
TFS HealthScience and Oncomatryx Join Forces for OMTX705 Pancreatic Cancer Trial#USA#Lund#pancreatic_cancer#TFS_HealthScience#Oncomatryx
TFS HealthScience and Oncomatryx Join Forces for OMTX705 Pancreatic Cancer Trial
TFS HealthScience is furthering its partnership with Oncomatryx to conduct a Phase Ib trial of OMTX705, a potential treatment for pancreatic cancer.
third-news.com
May 6, 2025 at 7:10 AM
newsen.bsky.social
Unraveling the Complex Interplay of Nerves in Pancreatic Cancer Development#USA#Cancer_Research#pancreatic_cancer#Cold_Spring_Harbor
Unraveling the Complex Interplay of Nerves in Pancreatic Cancer Development
New research reveals how nerve interactions significantly contribute to pancreatic cancer initiation and progression, suggesting novel treatment pathways.
third-news.com
February 9, 2026 at 3:11 PM
newsen.bsky.social
Exciting Phase 1 Data on DOC1021 Immunotherapy for Pancreatic Cancer Unveiled#United_States#Houston#pancreatic_cancer#Diakonos_Oncology#DOC1021
Exciting Phase 1 Data on DOC1021 Immunotherapy for Pancreatic Cancer Unveiled
Diakonos Oncology reveals promising Phase 1 data for DOC1021 therapy in pancreatic cancer, showcasing a boost in patient survival rates.
third-news.com
November 7, 2025 at 2:06 PM
newsen.bsky.social
Human Longevity, Inc. Enhances Commitment to Pancreatic Cancer with $1 Million Pledge Initiative#United_States#Inc.#pancreatic_cancer#South_San_Francisco#Precision_Medicine#Human_Longevity
Human Longevity, Inc. Enhances Commitment to Pancreatic Cancer with $1 Million Pledge Initiative
Human Longevity, Inc. expands its pancreatic cancer prevention commitment with a $1 million pledge for members diagnosed with late-stage cancer, ensuring access to advanced care.
third-news.com
June 17, 2025 at 12:44 PM
newsen.bsky.social
iOnctura's cambritaxestat Shows Potent Efficacy in Pancreatic Cancer at ESMO#None#Berlin#pancreatic_cancer#iOnctura#cambritaxestat
iOnctura's cambritaxestat Shows Potent Efficacy in Pancreatic Cancer at ESMO
iOnctura has presented promising clinical data on cambritaxestat, showcasing its efficacy in treating metastatic pancreatic cancer at ESMO 2025.
third-news.com
October 14, 2025 at 8:35 AM
newsen.bsky.social
Understanding the Impact of Oral Microbes on Pancreatic Cancer Risk: A Major Study#USA#New_York#NYU_Langone#pancreatic_cancer#oral_microbiome
Understanding the Impact of Oral Microbes on Pancreatic Cancer Risk: A Major Study
A significant study links 27 oral microbes to a 3.5 times increased risk of pancreatic cancer, shedding light on oral health's impact on cancer risks.
third-news.com
September 18, 2025 at 4:31 PM
newsen.bsky.social
GI Innovation and LaNova Medicines Forge Partnership for Pancreatic Cancer Treatment Development#South_Korea#Seoul#pancreatic_cancer#GI_Innovation#LaNova_Medicines
GI Innovation and LaNova Medicines Forge Partnership for Pancreatic Cancer Treatment Development
GI Innovation has partnered with LaNova Medicines to develop a combination therapy for pancreatic cancer, marking a significant step forward in treatment options.
third-news.com
January 22, 2025 at 1:17 PM
newsen.bsky.social
Pancreatic Cancer Survival Rates Remain Stagnant Amid Rising Diagnoses and Deaths#United_States#Los_Angeles#Cancer_Research#pancreatic_cancer#PanCAN
Pancreatic Cancer Survival Rates Remain Stagnant Amid Rising Diagnoses and Deaths
Recent statistics reveal that pancreatic cancer survival rates have stalled at a concerning 13%. The need for enhanced research and treatment strategies is crucial.
third-news.com
January 16, 2025 at 1:44 PM
newsen.bsky.social
Okayama University Initiates Phase I Clinical Trial for New Cancer Therapy Aimed at Pancreatic Cancer#Japan#pancreatic_cancer#Okayama#Okayama_University#OBP-702
Okayama University Initiates Phase I Clinical Trial for New Cancer Therapy Aimed at Pancreatic Cancer
Okayama University has commenced preparations for a Phase I clinical trial of OBP-702, a novel viral treatment for pancreatic cancer, showing promise based on animal studies.
third-news.com
April 11, 2025 at 4:39 PM
newsen.bsky.social
New Study Reveals Significant Disparities in Pancreatic Cancer Care and Survival Rates Among Patients#USA#pancreatic_cancer#Plymouth_Meeting#NCCN#Socio-Economic_Disparities
New Study Reveals Significant Disparities in Pancreatic Cancer Care and Survival Rates Among Patients
A recent study highlights stark differences in treatment quality and survival outcomes for pancreatic cancer patients from socio-economically disadvantaged backgrounds. The findings raise urgent calls for targeted interventions.
third-news.com
April 9, 2025 at 2:33 PM
newsen.bsky.social
Continuity Biosciences Executes Strategic Acquisition of Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer#USA#pancreatic_cancer#Bradenton#Continuity_Biosciences#Focal_Medical
Continuity Biosciences Executes Strategic Acquisition of Focal Medical to Enhance Targeted Drug Delivery for Pancreatic Cancer
Continuity Biosciences has successfully acquired Focal Medical, aiming to revolutionize targeted drug delivery in pancreatic cancer treatment with innovative iontophoresis technology.
third-news.com
June 4, 2025 at 12:30 PM
newsen.bsky.social
Immunovia Unveils Financial Calendar for 2025-2026: Key Dates Announced#Sweden#Immunovia#Lund#pancreatic_cancer#blood_diagnostics
Immunovia Unveils Financial Calendar for 2025-2026: Key Dates Announced
Immunovia has revealed its financial calendar for 2025/2026, detailing crucial reporting dates and the Annual General Meeting, aimed at enhancing cancer diagnostics.
third-news.com
December 11, 2024 at 11:59 AM
mmalumbres.bsky.social
Adding vitamin C to gemcitabine-paclitaxel doubles survival in pancreatic cancer. www.sciencedirect.com/science/arti...

#Vitamin C and #pancreatic_cancer!
A clinical trial in "Redox Biology" 🤨

Anyone can help with possible flaws in this study?
It is a very serious question.

#oncosky #oncsky 🧪
A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer - PubMed
P-AscH<sup>-</sup> infusions of 75 g three times weekly in patients with metastatic pancreatic cancer prolongs overall and progression free survival without detriment to quality of life or added toxic...
pubmed.ncbi.nlm.nih.gov
December 5, 2024 at 4:11 PM
newsen.bsky.social
First Patient Enrolled in Phase 2 Trial for Innovative Therapy in Late-Stage Pancreatic Cancer#Israel#Clinical_Trial#pancreatic_cancer#Amorphical#Nes_Ziona
First Patient Enrolled in Phase 2 Trial for Innovative Therapy in Late-Stage Pancreatic Cancer
Amorphical has enrolled the first patient for its Phase 2 clinical trial evaluating a novel therapy aimed at mitigating stage IV pancreatic cancer, aiming to improve patient survival rates.
third-news.com
November 24, 2025 at 1:39 PM
newsen.bsky.social
FDA Grants Third Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer Treatment#United_States#San_Francisco#pancreatic_cancer#Utidelone#Biostar_Pharma
FDA Grants Third Orphan Drug Designation to Biostar Pharma's Utidelone for Pancreatic Cancer Treatment
Biostar Pharma's Utidelone receives Orphan Drug Designation from the FDA to treat pancreatic cancer, highlighting its potential benefits against this difficult disease.
third-news.com
September 25, 2025 at 3:05 PM
newsen.bsky.social
Immunovia Reports 2024 Results, Holding Promise for Pancreatic Cancer Detection#Sweden#Immunovia#Lund#pancreatic_cancer#diagnostics
Immunovia Reports 2024 Results, Holding Promise for Pancreatic Cancer Detection
Immunovia shares insights on its financial performance and advancements in pancreatic cancer detection, showcasing their innovative new test.
third-news.com
February 25, 2025 at 7:57 AM
cornelius1ste.bsky.social
"LAS VEGAS (KLAS) — A research team at the University of Nevada, Las Vegas claims its latest discovery could eventually lead to curing pancreatic cancer and diabetes." #pancreatic_cancer #cancer #diabetes

www.8newsnow.com/news/local-n...
UNLV research team claims discovery could lead to finding cure for pancreatic cancer, diabetes
A research team at the University of Nevada, Las Vegas claims its latest discovery could eventually lead to curing pancreatic cancer and diabetes.
www.8newsnow.com
August 7, 2025 at 5:14 PM
newsen.bsky.social
Immunovia Announces Exercise Price for Second Warrant Series and Secures Funding Support#Sweden#Immunovia#Lund#pancreatic_cancer#Warrant_Programme
Immunovia Announces Exercise Price for Second Warrant Series and Secures Funding Support
Immunovia AB has set the exercise price for its TO 2 warrants, securing significant funding commitments to support its pancreatic cancer diagnostic initiatives.
third-news.com
December 28, 2024 at 3:09 PM
newsen.bsky.social
Oncolytics Biotech's Strong Regulatory Progress in Oncology Trials for 2025#USA#San_Diego#pancreatic_cancer#Oncolytics_Biotech#pelareorep
Oncolytics Biotech's Strong Regulatory Progress in Oncology Trials for 2025
Oncolytics Biotech®, advancing clinical trials for pancreatic and anal cancer treatments, shows promising regulatory milestones and efficacy signals.
third-news.com
February 19, 2025 at 12:15 PM
newsen.bsky.social
Immunovia Sets Exercise Price for Warrant Series TO 2, Securing 65% Funding for Future Projects#Sweden#Immunovia#Lund#pancreatic_cancer#Warrants
Immunovia Sets Exercise Price for Warrant Series TO 2, Securing 65% Funding for Future Projects
Immunovia AB has confirmed an exercise price for its warrants series TO 2, securing significant funds necessary for advancing pancreatic cancer diagnostics in the US market.
third-news.com
December 28, 2024 at 3:11 PM
newsen.bsky.social
Continuity Biosciences Acquires Focal Medical to Enhance Pancreatic Cancer Treatment#USA#pancreatic_cancer#Bradenton#Continuity_Biosciences#Focal_Medical
Continuity Biosciences Acquires Focal Medical to Enhance Pancreatic Cancer Treatment
Continuity Biosciences has secured Focal Medical, enhancing their ability to deliver targeted therapies for pancreatic cancer through innovative drug delivery methods.
third-news.com
June 4, 2025 at 12:37 PM